However, a significant trend was observed in the positive rate of m SEPT9 increasing with the disease stage, notably from 40% in stage I to 90% in stage IV, with stages III and IV exhibiting the highest positivity rates at 75% and 90%, respectively (Chi-square test, p = 0.049).
← all excerpts
Innovative Semi-Nested Realtime PCR Assay with Extendable Blocking Probe for Enhanced Analysis of <i>SEPT9</i> Methylation in Colorectal Cancer.
1
—
—